EUVIMEDEUVIMED entdecken
Crossref

Clinical Efficacy of Topical Nitroglycerin Ointment for Patients With Empty Nose Syndrome

Sung Seok Ryu iD, Sohee Kang, Yong Ju Jang

The Laryngoscope · 2026-12 · 136 (12) · 5254-5261

DOI: 10.1002/lary.70661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 05.06.2026. Verfasst von Sung Seok Ryu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Nitroglycerin, Nose Diseases, Vasodilator Agents. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The objective of this study was to assess the clinical efficacy and safety of topical nitroglycerin ointment in patients diagnosed with empty nose syndrome (ENS).

Methods

ENS was diagnosed based on clinical history, nasal endoscopic findings, a positive cotton test, and an Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q) score of ≥ 11. Patients who met the inclusion criteria were instructed to apply a topical nitroglycerin ointment (Rectogesic, glyceryl trinitrate 0.2%) three times daily. The mean age was 42.09 years, with a male‐to‐female ratio of 3:1. Pre‐ and posttreatment ENS6Q scores were compared, and subjective symptom improvement was analyzed.

Results

The total ENS6Q score showed a significant improvement, dropping from 17.32 ± 4.34 to 12.52 ± 5.21 ( p < 0.001). All six ENS6Q items showed significant improvements, with the greatest reduction observed in nasal dryness (4.16 to 2.86, p < 0.001). Sixteen patients (36.4%) showed moderate improvement (ΔENS6Q = 3 to 6). Fifteen patients (34.1%) showed marked improvement (ΔENS6Q > 6), exceeding the minimal clinically important difference. Subjective symptom improvement was reported by 27 patients (61.4%), who demonstrated significantly greater ENS6Q improvement than those without symptom improvement (ΔENS6Q 7.22 ± 4.99 vs. 0.94 ± 2.41, p < 0.001). Eleven patients (25.0%) reported adverse effects; mild headache was the most common symptom ( n = 6, 54.5% of adverse effects). The presence of adverse effects did not have a significant impact on treatment duration.

Conclusions

Topical nitroglycerin showed promising preliminary results and may represent a potential conservative treatment option for ENS, an uncommon yet serious complication arising after turbinate volume reduction surgery. Level of Evidence 4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NitroglycerinNose DiseasesVasodilator AgentsHumansMaleFemaleAdultOintmentsSyndromeTreatment OutcomeAdministration, TopicalMiddle AgedSurveys and Questionnaires

Stichwörter der Autor:innen

empty nose syndromeintranasalnitroglycerinsymptom assessmentturbinate surgery

Substanzen

NitroglycerinOintmentsVasodilator Agents

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Sung Seok Ryu

Zitieren

APA

Ryu, S. S., Kang, S., & Jang, Y. J. (2026). Clinical Efficacy of Topical Nitroglycerin Ointment for Patients With Empty Nose Syndrome. The Laryngoscope, 136(12), 5254-5261. https://doi.org/10.1002/lary.70661

Vancouver

Ryu SS, Kang S, Jang YJ. Clinical Efficacy of Topical Nitroglycerin Ointment for Patients With Empty Nose Syndrome. The Laryngoscope. 2026;136(12):5254-5261. doi:10.1002/lary.70661

BibTeX
@article{Ryu2026,
  author = {Ryu, Sung Seok and Kang, Sohee and Jang, Yong Ju},
  title = {Clinical Efficacy of Topical Nitroglycerin Ointment for Patients With Empty Nose Syndrome},
  journal = {The Laryngoscope},
  year = {2026},
  volume = {136},
  number = {12},
  pages = {5254--5261},
  doi = {10.1002/lary.70661}
}
Kostenlos starten →